Clinical evidence - Non-metastatic prostate cancer

被引：0
|
作者：
Wilt, TJ
Brawer, MK
机构：
[1] NW Prostate Inst, Seattle, WA 98133 USA
[2] Minneapolis VA Hosp, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA
来源：
WESTERN JOURNAL OF MEDICINE | 1999年 / 171卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article comes from Clinical Evidence, a new resource for clinicians, produced jointly by the BMJ Publishing Group and the American College of Physicians-American Society of Internal Medicine. Clinical Evidence is an extensively peer-reviewed publication that summarizes the best available evidence on the effects of common clinical interventions gleaned from thorough searches and appraisal of the world literature. The first issue is available in book form in the United Kingdom, with a United States version planned for publication in October. The second issue, updated and expanded to cover more topics and questions, will be published 6 months later. Please see the advertisement For more information or visit our web site at www.evidence.org.
引用
收藏
页码：97 / 101
页数：5
相关论文
共 50 条
  • [21] THE MANAGEMENT OF NON-METASTATIC CARCINOMA OF THE PROSTATE
    MARSHALL, VR
    MOSS, D
    NEERHUT, KJ
    RUSSELL, J
    WIGG, D
    SINCLAIR, G
    BRITISH JOURNAL OF UROLOGY, 1984, 56 (01): : 88 - 88
  • [22] Clinical Outcomes in a Locally Advanced Non-metastatic Prostate Cancer Presenting with Low PSA at Diagnosis
    Haris, M.
    Maitre, P.
    Logue, J.
    Wylie, J.
    Hoskin, P.
    Choudhury, A.
    CLINICAL ONCOLOGY, 2024, 36 (01) : E80 - E81
  • [23] Evidence-based radiation oncology: Definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer
    Jereczek-Fossa, Barbara Alicja
    Orecchia, Roberto
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 (02) : 197 - 215
  • [24] UNDERTREATMENT OF MEN IN THEIR SEVENTIES WITH HIGH RISK, NON-METASTATIC PROSTATE CANCER
    Stattin, Par
    Eriksson, Marie Hjalm
    Lissbrant, Ingela Franck
    Folkvaljon, Yasin
    Akre, Olof
    Carlsson, Stefan
    Drevin, Linda
    Makarov, Daniel
    Loeb, Stacy
    Bratt, Ola
    JOURNAL OF UROLOGY, 2015, 193 (04): : E687 - E687
  • [25] The Impact of Cell-free Plasma DNA on Metastatic and Non-metastatic Prostate Cancer
    Abonar, Abdelraouf A.
    Ayoub, Shymaa E.
    A.Tagreda, Ibrahim
    Abdelhafez, Marwa N.
    Khamiss, Mohammed M.
    Abdelaziz, Mohamed I.
    Gaber, Sylvana N.
    Amin, Amal
    Mohammed, Shereen R.
    CURRENT MOLECULAR MEDICINE, 2022, 22 (01) : 67 - 73
  • [26] The earlier the better? Apalutamide for non-metastatic castration resistant prostate cancer
    De Santis, Maria
    Steuber, Thomas
    ESMO OPEN, 2019, 4 (02)
  • [27] PSA MONITORING AND RESULTS AMONG MEN WITH NON-METASTATIC PROSTATE CANCER
    Wilson, K. L.
    Foley, K. A.
    VALUE IN HEALTH, 2014, 17 (03) : A96 - A96
  • [28] ADT/Abiraterone Acetate/Prednisolone for Patients with non-metastatic Prostate Cancer
    Di Lellis, Maddalena Angela
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (15) : 955 - 956
  • [29] Non-metastatic castration-resistant prostate cancer: management recommendations
    Alcaraz Asensio, A.
    Alvarez Ossorio, J. L.
    Cozar Olmo, J. M.
    Chantada Abal, V
    Juarez Soto, A.
    Espinos, E. Linares
    Moreno Jimenez, J.
    Munoz Rodriguez, J.
    Perez Fentes, D.
    Plata Bello, A.
    Rodrigo Aliaga, M.
    Unda Urzaiz, M.
    Vilaseca, A.
    ACTAS UROLOGICAS ESPANOLAS, 2022, 46 (04): : 193 - 213
  • [30] Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
    Lesley J. Scott
    Targeted Oncology, 2020, 15 : 791 - 799
12345